Percutaneous Coronary Intervention News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Surgery improves survival in diabetic patients with heart disease
Among diabetic patients with severe heart disease, coronary artery bypass grafting (CABG) surgery is better than stenting (percutaneous coronary intervention; PCI) at improving long-term survival and reducing the risk of adverse complications, a study confirms. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 1, 2015 Category: Science Source Type: news

Abiomed Impella 2.5 Receives FDA Approval For Elective And Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures
Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that it has received U.S. (Source: Medical Design Online News)
Source: Medical Design Online News - March 25, 2015 Category: Medical Equipment Source Type: news

FDA approves blood pump system to help patients maintain stable heart function during certain high-risk cardiac procedures
The U.S. Food and Drug Administration today approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary intervention (HRPCI) procedures, such as balloon angioplasty and stenting, which re-open coronary arteries that are narrowed or blocked due to severe coronary artery disease (CAD). (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 23, 2015 Category: American Health Source Type: news

Findings from the BRIGHT trial published in JAMA
(Cardiovascular Research Foundation) Data from the BRIGHT trial published today in the Journal of the American Medical Association demonstrated that bivalirudin was superior to both heparin monotherapy and heparin plus tirofiban for patients with acute myocardial infarction undergoing percutaneous coronary intervention. Findings were first reported at last year's Transcatheter Cardiovascular Therapeutics, the annual scientific symposium of the Cardiovascular Research Foundation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2015 Category: Global & Universal Source Type: news

A Requiem for Routine Thrombectomy? (FREE)
By Larry Husten Edited by Jaye Elizabeth Hefner, MD New findings from the industry-funded TOTAL study cast further doubt on the role for routine thrombectomy in patients undergoing percutaneous coronary intervention for acute myocardial infarction. The findings were presented at the American … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 17, 2015 Category: Primary Care Source Type: news

CABG vs. PCI for Multivessel CAD: Do Second-Generation Stents Make a Difference? (FREE)
By Howard C. Herrmann, MD Second-generation stents narrow the gap between coronary artery bypass grafting and percutaneous coronary intervention for nondiabetic patients with multivessel disease, according to findings from two studies published in the New England Journal of Medicine. The studies provide a wealth of data informing clinicians and patients about the differences between CABG and PCI for multivessel coronary artery disease. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 17, 2015 Category: Primary Care Source Type: news

Hold Prasugrel Until Revascularization Decision Is MadeHold Prasugrel Until Revascularization Decision Is Made
Prasugrel treatment should be delayed until after a decision is made about revascularization in patients undergoing percutaneous coronary intervention (PCI) for non-ST-elevation myocardial infarction (NSTEMI). Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2014 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

LVEF for Risk Stratification in Prevention of SCD After MILVEF for Risk Stratification in Prevention of SCD After MI
What ejection fraction threshold identifies patients with a high incidence of inducible VT post- primary percutaneous coronary intervention? Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2014 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

New Study Assesses The Utility Of Optical Coherence Tomography During Stent Implantation In Primary PCI
The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported today at the 26thannual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. (Source: Medical Design Online News)
Source: Medical Design Online News - September 19, 2014 Category: Medical Equipment Source Type: news

Intravascular ultrasound-guided intervention in patients with chronic total occlusion
A new study found that intravascular ultrasound (IVUS)-guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous coronary intervention. The IVUS-CTO study is the first randomized trial to examine the clinical impact of IVUS guidance for CTO intervention. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 16, 2014 Category: Science Source Type: news

Optical coherence tomography in primary percutaneous coronary intervention
The first randomized trial to examine serial optical coherence tomography in primary percutaneous coronary intervention was reported today. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 16, 2014 Category: Science Source Type: news

TCT: Bivalirudin Cuts Bleeding in PCI
WASHINGTON (MedPage Today) -- A prolonged infusion of bivalirudin (AngioMax) around percutaneous coronary intervention reduced bleeding compared with heparin, with or without glycoprotein IIb/IIIa inhibition, a Chinese trial showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 15, 2014 Category: Cardiology Source Type: news

Plucking Clot Fails to Improve PCI Outcome
(MedPage Today) -- A year after treatment, patients who underwent aspiration of thrombus before undergoing percutaneous coronary intervention fared no better than those treated with standard PCI alone. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 4, 2014 Category: Cardiology Source Type: news

ESC: Ultrathin Stent Proves Mettle in Post-PCI Patients (CME/CE)
BARCELONA (MedPage Today) -- An ultrathin biodegradable sirolimus-eluting stent (Orsiro) proved noninferior to a durable polymer everolimus-eluting stent (Xience) a year after percutaneous coronary intervention (PCI), researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 1, 2014 Category: Cardiology Source Type: news

ESC: No Pre-PCI Boost from Brilinta in Ambulance (CME/CE)
BARCELONA (MedPage Today) -- Giving the antiplatelet drug ticagrelor (Brilinta) in the ambulance to patients with acute ST-segment elevation myocardial infarction didn't improve coronary reperfusion before percutaneous coronary intervention, researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 1, 2014 Category: Cardiology Source Type: news